Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
21.48
+0.22 (1.03%)
At close: Dec 5, 2025
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,557 employees as of December 31, 2024. The number of employees increased by 187 or 0.46% compared to the previous year.
Employees
40,557
Change (1Y)
187
Growth (1Y)
0.46%
Revenue / Employee
1.07M HKD
Profits / Employee
88.46K HKD
Market Cap
74.33B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| JD Health International | 3,564 |
| Innovent Biologics | 5,659 |
| WuXi Biologics | 12,575 |
| Sino Biopharmaceutical | 24,379 |
| Akeso | 3,035 |
| Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
Shanghai Fosun Pharmaceutical (Group) News
- 2 months ago - China’s ‘health silk road’ in Africa gets a boost with insulin, pharma projects - South China Morning Post
- 2 months ago - Fosun’s Henlius in talks with Johnson & Johnson, Roche on cancer drug - South China Morning Post
- 9 months ago - Shanghai Fosun Pharmaceutical reports FY results - Seeking Alpha
- 2 years ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 3 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
- 4 years ago - Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal - Seeking Alpha
- 4 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 4 years ago - Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse - Seeking Alpha